China Veterinary Drug Registration & Veterinary Regulatory Affairs Consulting

Securing approval for veterinary drugs, pet care products, and feed additives in China involves navigating a complex landscape of regulations, classifications, and administrative processes—each governed by distinct authorities and technical standards. Whether you are introducing a new veterinary drug, launching an innovative product for companion animals, or registering nutritional additives for livestock, success depends on understanding and fulfilling the specific regulatory obligations for each category.

Cisema provides specialized regulatory affairs consulting across all areas of veterinary product registration in China. We support companies throughout the full product lifecycle, from strategic planning and dossier preparation to testing coordination, labeling compliance, and post-market maintenance. With deep knowledge of Chinese legislation and direct engagement with the Ministry of Agriculture and Rural Affairs, our experts help you mitigate approval risks, reduce time to market, and maintain long-term compliance under the legal framework established by the People's Republic of China and the administrative oversight of the people's government.

Animal health and pet care in China
China veterinary drug registration
Animal health and pet care in China

Our strength lies in our focused expertise in China veterinary drug registration. Whether you are seeking approval for imported veterinary drugs, renewing an existing license, or preparing a submission for a novel treatment or biological product, we offer practical, step-by-step support. Our team manages every aspect of the process, including preparation of application materials, coordination of technical evaluations, and communication with regulatory authorities to ensure a smooth and efficient pathway to approval. We help clients navigate the various measures and quality control standards required for compliance.

From chemical drugs and vaccines to over-the-counter pet solutions and animal feed supplements, we deliver tailored regulatory strategies to help animal health companies confidently access and grow in the Chinese market.

Regulatory Background

The regulatory affairs landscape for veterinary drugs in China is managed by the Ministry of Agriculture and Rural Affairs (MARA), which sets comprehensive standards to ensure the safety, efficacy, and quality of all veterinary drugs used within the country. These regulations are designed to oversee the entire lifecycle of veterinary drugs, from the initial development and registration of new veterinary drugs and imported veterinary drugs, through to the conduct of clinical trials and ongoing administration.

In China, veterinary drugs are defined as substances intended to prevent, treat, or diagnose animal diseases, as well as to regulate animal physiological functions. This broad definition encompasses not only traditional pharmaceuticals, but also vaccines, diagnostic reagents, disinfectants, topical pesticides, and pharmaceutical feed additives. The regulatory framework requires that all such products undergo rigorous evaluation and registration to ensure they meet national safety and quality standards.

The primary objective of these regulations is to protect both animal and human health, recognizing the close connection between animal diseases and public health outcomes. By enforcing strict controls on the production, distribution, and use of veterinary drugs, the Ministry of Agriculture and Rural Affairs supports the sustainable development of China’s animal husbandry and breeding industries. This regulatory environment also encourages scientific research and innovation, ensuring that new veterinary drugs and imported products contribute positively to the country’s agricultural and rural affairs goals.

Veterinary Drug Registration in China

Strategic Guidance for Successful Approval

The process of veterinary drug registration in China is governed by the Veterinary Drug Administration Regulations, supervised by the Ministry of Agriculture and Rural Affairs. Applicants must register their veterinary drugs by submitting all required documentation and data to the authorities. A typical registration includes mandatory product testing, submission of registration materials, and in some cases, clinical trials or on site inspections. The data submitted, including safety evaluations, laboratory reports, and efficacy data, must meet regulatory standards for review and approval.

Cisema provides expert support for the registration of veterinary drugs in the following categories:

New veterinary drugs
Generic drugs
Imported veterinary drugs
Traditional Chinese veterinary medicine.

We guide you through every step, including:

Determining if your veterinary drug product meets conditions for simplified registration or requires a full technical evaluation
Preparing and translating your application form, approval documents, and other relevant materials in accordance with Chinese regulations
Managing required entrusted tests, compiling original test reports, and coordinating conduct on site inspection when necessary
Supporting clinical trial protocol design for novel drugs or new indications
Liaising with the China Institute for Veterinary Drug Control (IVDC) and other testing bodies
Submitting a complete registration dossier and following up with the authority through the administrative examination.
Ensuring all data submitted, including safety evaluations and laboratory reports, meets regulatory standards.

Other data, such as supplementary documentation, may be required depending on the product type or following circumstances specified by the authorities.

Once approved, we assist in obtaining the veterinary drug registration certificate, ensuring correct use of the approval number, and supporting long-term compliance under the authority of the State Council and the government agencies involved. The veterinary drug registration certificate is valid for five years, after which re-registration or renewal is necessary.

During the process, there is a specific time limit for regulatory authorities to review and approve submitted applications, ensuring timely processing and oversight.

Veterinary drugs must be produced in accordance with Good Manufacturing Practices, and only drugs produced in licensed facilities are eligible for registration. For certain urgently needed veterinary drugs, special procedures may allow for expedited review or importation under specific circumstances.

Pet Care Product Compliance

Accurate Classification and Regulatory Alignment

In China, not all animal health products are classified as veterinary drugs. For pet care products, the correct classification is essential to avoid incorrect submission and costly delays. Products such as flea and tick treatments, skin care, grooming sprays, and dental chews may fall under veterinary drug administration, general consumer product law, or agriculture and rural affairs regulations.

Cisema helps you:

Accurately classify the product belongs to the correct category
Ensure compliant packaging materials, claims, and instructions
Avoid unapproved therapeutic claims that could trigger additional approval obligations
Prepare for customs clearance and submit correct relevant materials to local authorities
Act as your local entity engaged in communications with MARA or SAMR.

Feed Additive Registration in China

Feed additives are regulated independently of veterinary drugs, though some may overlap in classification. Whether for livestock or pets, registration is required before importation or sale.

Our services cover:

Quality standards assessment and identification of active ingredients
Preparation of application materials, safety data, and approval documents
Assistance with testing and adverse reactions monitoring
Coordination with laboratories recognized by the general administration
Support in labeling, market launch, and ongoing compliance management.
For biological feed additives or products derived from cell cultures, we ensure documentation regarding the origin and safety of cell lines is included in your application materials.


For companies active in the breeding industry, nutrition, or epidemic disease control, we ensure your feed additives meet MARA’s standards and regulatory expectations.

Feed additives registration materials

Why Work with Cisema?

In-country regulatory expertise

Local knowledge, direct access to MARA and the China Institute of Veterinary Drug Control

Veterinary product focus

Specialized knowledge across veterinary drugs, biological products, and feed additives

Lifecycle support

From dossier creation to post-market compliance and renewals

Proven results

Trusted by global leaders in animal health, diagnostics, and scientific research.

Role of a China Agent

Request a Proposal for Veterinary Services

Request Proposal

Other Industries We Support

In addition to IVDs, we offer consulting services across regulated industries including medical devices, pharmaceuticals, biopharma, cosmetics, health foods, veterinary products, and other industrial and consumer goods. Our team ensures tailored regulatory compliance strategies, regardless of product category or manufacturing model.

Medical Devices

Pharmaceuticals

Biotech

In-Vitro Diagnostics

Health Foods & Supplements

Cosmetics

Industrial Goods & Consumer Products

Latest Insights

View More

Malaysia NPRA Updates Cosmetic Ingredient Requirements Under the ASEAN Cosmetic Directive

Circular No. 2/2026 revises prohibited, restricted, colorant, and preservative requirements for cosmetics marketed in Malaysia.

August 20, 2026
Malaysia NPRA Updates Cosmetic Ingredient Requirements Under the ASEAN Cosmetic Directive

China Overhauls Cosmetic Safety Rules with GB 7916-2026: Is Your Brand Ready?

Brands must audit ingredients, suppliers and packaging before January 2028 to ensure compliance with GB 7916-2026.

August 18, 2026
China Overhauls Cosmetic Safety Rules with GB 7916-2026: Is Your Brand Ready?
Scientist in clean modern room inspects cosmetics.

China Expands Animal Testing Data Exemptions in Major Cosmetics Registration and Filing Reform

Companies can benefit from expanded toxicology data exemptions, simplified cosmetics registration procedures, and more efficient compliance pathways

August 18, 2026
China Expands Animal Testing Data Exemptions in Major Cosmetics Registration and Filing Reform

Taiwan Extends Cosmetic GMP Requirements to Nearly All Manufacturing Sites

As of July 1, 2026, Taiwan has completed its cosmetic GMP rollout, extending mandatory ISO 22716-based manufacturing standards to nearly all cosmetic factories

August 18, 2026
Taiwan Extends Cosmetic GMP Requirements to Nearly All Manufacturing Sites

China Updates New Cosmetic Ingredient Registration Rules: Several Higher-Risk Ingredient Categories Removed

New NCI rules reduce administrative burden, streamline dossiers, and expand opportunities to reuse existing safety data.

August 18, 2026
China Updates New Cosmetic Ingredient Registration Rules: Several Higher-Risk Ingredient Categories Removed
This stock photo features a close-up, high-angle shot focusing on a skincare product arrangement set against a light-colored, wood-grain surface.

NMPA Opens Consultation on Two Draft Cosmetic Adverse Reaction Standards: Cosmetic Cheilitis & Cosmetic Contact Urticaria

Review China's new draft standards for cosmetic cheilitis and contact urticaria before the August 15, 2026, consultation deadline.

August 18, 2026
NMPA Opens Consultation on Two Draft Cosmetic Adverse Reaction Standards: Cosmetic Cheilitis & Cosmetic Contact Urticaria
Previous
Previous

Get in Touch with Our Veterinary Regulatory Affairs Consultants

Speak with our consultants to discuss how our expert services for China veterinary drug registration can support your entry into one of the world's largest veterinary markets.

Request Proposal